Exposure to statins is associated to fracture risk reduction in elderly people with cardiovascular disease: evidence from the AIFA-I-GrADE observational project-Reference-Cited by-同舟云学术

Exposure to statins is associated to fracture risk reduction in elderly people with cardiovascular disease: evidence from the AIFA-I-GrADE observational project

Published:2017-03-31 Issue:7 Volume:26 Page:775-784
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Rea Federico¹^ORCID,Bonassi Stefano²³,Vitale Cristiana⁴,Trifirò Gianluca⁵,Cascini Silvia⁶,Roberto Giuseppe⁷^ORCID,Chinellato Alessandro⁸,Lucenteforte Ersilia⁹,Mugelli Alessandro⁹,Corrao Giovanni¹,

Affiliation:

1. Laboratory of Healthcare Research & Pharmacoepidemiology, Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods; University of Milano-Bicocca; Milan Italy

2. Department of Human Sciences and Quality of Life Promotion; San Raffaele University; Rome Italy

3. Unit of Clinical and Molecular Epidemiology; IRCCS San Raffaele Pisana; Rome Italy

4. Department of Medical Sciences; IRCCS San Raffaele Pisana; Rome Italy

5. Department of Biomedical and Dental Sciences and Morphofunctional Imaging; University of Messina; Messina Italy

6. Department of Epidemiology; Lazio Regional Health Service; Rome Italy

7. Epidemiology Unit; Regional Agency for Healthcare Services of Tuscany; Florence Italy

8. Treviso Local Health Unit; Treviso Italy

9. Department of Neurosciences, Psychology, Drug Research and Children's Health; University of Florence; Florence Italy

Funder

Agenzia Italiana del Farmaco, Ministero della Salute

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference48 articles.

1. ESC/EAS guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS);Catapano;Atherosclerosis,2011

2. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomized trials of statins;The Cholesterol Treatment Trialists' Collaborators;Lancet,2005

3. The safety of statins in clinical practice;Armitage;Lancet,2007

4. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute;Smith;Circulation,2006

5. The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011;Ray;Eur Heart J,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Author's Reply: “A retrospective analysis of treatment patterns, drug discontinuation and healthcare costs in Crohn's disease patients treated with biologics”;Digestive and Liver Disease;2024-01

2. Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture in older adults;Osteoporosis International;2023-08-08

3. Medications influencing the risk of fall-related injuries in older adults: case–control and case-crossover design studies;BMC Geriatrics;2023-07-22

4. Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN‐SPIDERS;British Journal of Clinical Pharmacology;2022-05-22

5. Quality of reporting of drug exposure in pharmacoepidemiological studies;Pharmacoepidemiology and Drug Safety;2020-05-11